ATLANTA, GA – July 20, 2016:

Bethany Bray, Chief Executive Officer and Co-Founder of AutoCruitment recently presented at the DIA Annual Meeting in Philadelphia, PA.

Drug Information Association (DIA) is the only global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide and has become an essential resource that provides opportunities to extend debate and discussion to advance scientific and medical innovation.

The session entitled “Patient Recruitment in Rare Diseases: Ideas and Framework for out-of-the-Box Exploration”, explored the challenges of recruiting patient participants in clinical studies involving rare diseases where populations are small and geographically dispersed. The aim of the session was to “catalyze unconventional thinking and to provide a framework to organize innovative recruitment ideas.” The discussion focused on patient recruitment, retention, engagement and clinical trial designs.

Bethany’s presentation, “Direct-to-Patient Digital Recruitment: A Targeted Approach to Recruitment Enrollment and Retention”, addressed how targeted digital marketing techniques can be used to target, engage and recruit the right patients in the external patient population; improving recruitment, enrollment and retention problems in clinical trials. An Oncology and Neuroscience Researcher, Entrepreneur and Technologist, Bethany founded AutoCruitment to fulfill a vision of utilizing the power of the internet to address patient recruitment, enrollment and retention problems in clinical trials.

“It was an honor to be asked to speak at DIA. As a company we were impressed with the number of sessions that discussed how Sponsors and CROs approach patient recruitment, highlighting that typically Sponsors and CROs will rely solely on research sites or key opinion leaders (KOLs) to recruit patients from existing databases, which creates a bottleneck. We couldn’t agree more.” comments Bray. “There is a need to devise strategies to reach out to patients in the external community directly. A targeted digital recruitment strategy allows us to attract the right patients in the external community, screen them online and automatically and immediately refer them to the KOLs or contracted research sites; removing the bottleneck and ultimately accelerating the trial timeline.”

AutoCruitment is able to provide a path to effective digital marketing presence through a proprietary and targeted, direct-to-patient, online marketing platform that targets, recruits, screens and automatically refers new patients for clinical trials or specialty medical procedures. By streamlining the recruitment process, AutoCruitment helps accelerate the commercialization of safe, effective new treatments for devastating diseases and conditions and directs patients to new and suitable providers.

“DIA was an excellent opportunity for AutoCruitment to highlight the innovative strategies that we are employing to accelerate patient recruitment. Getting the buy-in from CROs and Sponsors is incredibly important in adopting new digital technologies to improve not just patient recruitment but the overall outcome of the clinical trial or specialty study.”

To learn more about how AutoCruitment can develop unique strategies to support your clinical trials, contact AutoCruitment at info@autocruitment.com or visit www.autocruitment.com

July 21, 2016 , by AutoCruitment

Never Miss Any News

Join our community and get notified of any new articles.



If you enjoyed this AutoCruitment article,
you'll probably like

AutoCruitment’s patient recruitment platform supports Sponsors, CRO Partners and Research Sites by decreasing time,
risk and cost to bring new therapies to market.

Contact Us